ArticleJAMA ophthalmology2022

Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants.

Writing Committee for the Pediatric Eye Disease Investigator Group et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.